XML 28 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segment Information (Tables)
6 Months Ended
Jun. 30, 2020
Business Segment Information  
Schedule of operating results by business segment

The following tables summarize, for the periods indicated, operating results by business segment (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

    

​

​

    

Corporate

    

​

​

 

​

​

​

​

​

Pharmacy

​

and

​

​

​

 

​

    

Healthcare

    

Management

    

Elimination

    

Consolidated

 

Three Months Ended June 30, 2019

​

​

​

​

​

​

​

​

​

​

​

​

​

Managed care and other revenue

​

$

546,113

​

$

62,648

​

$

(147)

​

$

608,614

​

PBM revenue

​

 

—

​

 

550,010

​

 

(4,335)

​

 

545,675

​

Cost of care

​

 

(408,911)

​

 

—

​

 

—

​

 

(408,911)

​

Cost of goods sold

​

 

—

​

 

(505,203)

​

 

4,122

​

 

(501,081)

​

Direct service costs and other

​

 

(98,314)

​

 

(78,776)

​

 

(18,817)

​

 

(195,907)

​

Stock compensation expense (1)

​

 

2,237

​

 

2,124

​

 

846

​

 

5,207

​

Segment Profit (Loss)

​

$

41,125

​

$

30,803

​

$

(18,331)

​

$

53,597

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

    

​

​

    

Corporate

    

​

​

​

​

​

​

​

​

Pharmacy

​

and

​

​

​

​

​

    

Healthcare

    

Management

    

Elimination

    

Consolidated

​

Three Months Ended June 30, 2020

​

​

​

​

​

​

​

​

​

​

​

​

​

Managed care and other revenue

​

$

481,021

​

$

67,867

​

$

(177)

​

$

548,711

​

PBM revenue

​

 

—

​

 

556,195

​

 

(4,831)

​

 

551,364

​

Cost of care

​

 

(321,831)

​

 

—

​

 

—

​

 

(321,831)

​

Cost of goods sold

​

 

—

​

 

(532,685)

​

 

4,618

​

 

(528,067)

​

Direct service costs and other

​

 

(100,450)

​

 

(80,082)

​

 

(19,224)

​

 

(199,756)

​

Stock compensation expense (1)

​

 

2,102

​

 

1,939

​

 

2,551

​

 

6,592

​

Segment Profit (Loss)

​

$

60,842

​

$

13,234

​

$

(17,063)

​

$

57,013

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

    

​

​

    

Corporate

    

​

​

 

​

​

​

​

​

Pharmacy

​

and

​

​

​

 

​

​

Healthcare

​

Management

​

Elimination

​

Consolidated

 

Six Months Ended June 30, 2019

​

​

​

​

​

​

​

​

​

​

​

​

​

Managed care and other revenue

​

$

1,052,935

​

$

122,543

​

$

(316)

​

$

1,175,162

​

PBM revenue

​

 

—

​

 

1,106,575

​

 

(8,442)

​

 

1,098,133

​

Cost of care

​

 

(778,008)

​

 

—

​

 

—

​

 

(778,008)

​

Cost of goods sold

​

 

—

​

 

(1,035,410)

​

 

8,015

​

 

(1,027,395)

​

Direct service costs and other (1)

​

 

(198,424)

​

 

(158,411)

​

 

(41,372)

​

 

(398,207)

​

Stock compensation expense (1)

​

 

3,780

​

 

3,796

​

 

7,031

​

 

14,607

​

Segment Profit (Loss)

​

$

80,283

​

$

39,093

​

$

(35,084)

​

$

84,292

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

    

​

​

    

Corporate

    

​

​

 

​

​

​

​

​

Pharmacy

​

and

​

​

​

 

​

​

Healthcare

​

Management

​

Elimination

​

Consolidated

 

Six Months Ended June 30, 2020

​

​

​

​

​

​

​

​

​

​

​

​

​

Managed care and other revenue

​

$

969,927

​

$

132,302

​

$

(350)

​

$

1,101,879

​

PBM revenue

​

 

—

​

 

1,129,973

​

 

(9,398)

​

 

1,120,575

​

Cost of care

​

 

(670,939)

​

 

—

​

 

—

​

 

(670,939)

​

Cost of goods sold

​

 

—

​

 

(1,070,259)

​

 

8,951

​

 

(1,061,308)

​

Direct service costs and other (1)

​

 

(206,386)

​

 

(161,948)

​

 

(35,663)

​

 

(403,997)

​

Stock compensation expense (1)

​

 

3,863

​

 

4,046

​

 

4,480

​

 

12,389

​

Segment Profit (Loss)

​

$

96,465

​

$

34,114

​

$

(31,980)

​

$

98,599

​

​

(1)Stock compensation expense, changes in the fair value of contingent consideration recorded in relation to acquisitions and impairment of intangible assets are included in direct service costs and other operating expenses; however, these amounts are excluded from the computation of Segment Profit.
Schedule of reconciliation of Segment Profit to income before income taxes

The following table reconciles income from continuing operations before income taxes to Segment Profit from continuing operations (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

​

​

​

June 30, 

​

June 30, 

​

​

​

2019

    

2020

    

2019

    

2020

​

Income from continuing operations before income taxes

​

$

12,950

​

$

10,780

​

$

1,550

​

$

15,472

​

Stock compensation expense

​

 

5,207

​

 

6,592

​

 

14,607

​

 

12,389

​

Depreciation and amortization

​

 

28,191

​

 

23,888

​

 

53,608

​

 

47,246

​

Interest expense

​

 

9,070

​

 

7,995

​

 

18,107

​

 

16,953

​

Interest and other income

​

 

(1,821)

​

 

(551)

​

 

(3,580)

​

 

(1,770)

​

Special charges

​

​

—

​

​

8,309

​

​

—

​

​

8,309

​

Segment Profit from continuing operations

​

$

53,597

​

$

57,013

​

$

84,292

​

$

98,599

​